Table for the 4 triples with object "The FDA recommends this as a CYP3A4/5 inhibitor for in vivo studies in it most recent guidance document. See Table 2, p. 19" sorted by label

SubjectPredicate
?:evidence_1326?:content
?:evidence_1591?:content
?:evidence_1625?:content
?:evidence_1699?:content